Large ASCERT Observational Study Favors CABG Over PCI
This article was originally published in The Gray Sheet
Executive Summary
Bypass graft surgery had a relative risk reduction of about 20% long term compared to stenting.
You may also be interested in...
FREEDOM Trial’s Data Favors CABG Over PCI For Patients With Diabetes
Patients in the trial showed significantly reduced rates in the composite outcome of death, heart attacks and strokes after five years with CABG versus percutaneous coronary intervention.
Research In Brief
Data from annual gatherings of the Society of Thoracic Surgeons and the American Stroke Association, and more.
CABG Beats DES In SYNTAX Trial; Observers Expect Little Change In Practice
Analysts and physicians predict one-year results from the SYNTAX trial will have little short-term impact on demand for drug-eluting stents, even though the devices performed worse than coronary artery bypass graft (CABG) surgery in this seminal randomized trial